Investigational Site Number : 724006

Madrid 28041

0 studies enrolling now · 2 studies all time

What they study most

Neoplasm Malignant, Squamous Cell Lung Cancer

Studies at this site

• Evaluation of SAR408701 in Patients With Advanced Solid Tumors — Stopped early
• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed